Pricing Log in Create free account

Kalaris Therapeutics Inc. (KLRS) vs Pliant Therapeutics, Inc. (PLRX)

Kalaris Therapeutics Inc. and Pliant Therapeutics, Inc. are both Biotechnology companies. Kalaris Therapeutics Inc. and Pliant Therapeutics, Inc. are of similar size ($51.6M and $50.5M). Across the 9 metrics below, Kalaris Therapeutics Inc. leads on 5 and Pliant Therapeutics, Inc. on 4.

Valuation

Metric KLRS PLRX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 9.98 9.40
P/B 1.01 0.34 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.33 0.81 0.66
EV/Sales n/m (15.42) 9.02
Earnings yield (85.64%) (183.95%) (32.88%)
Free cash flow yield (70.40%) (140.81%) (23.13%)

Profitability

Metric KLRS PLRX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (79.91%) (50.29%) (51.96%)
Return on assets (46.02%) (37.69%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KLRS PLRX Biotechnology median
Revenue growth (TTM) — (48.95%) 6.76%
EPS growth (last fiscal year) 94.50% 29.97% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KLRS PLRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.98 9.90 4.97
Net debt to EBITDA 2.54 1.27 1.01

Dividend

Metric KLRS PLRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KLRS PLRX Biotechnology median
Market cap 51.55m 50.52m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack